Akbarialiabad Hossein, Jamshidi Parnian, Callen Jeffrey P, Murrell Dédée F
Faculty of Medicine, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.
J Eur Acad Dermatol Venereol. 2025 May;39(5):976-986. doi: 10.1111/jdv.20098. Epub 2024 May 16.
Hereditary hemochromatosis (HH) is a genetic disorder leading to excessive iron absorption, impacting multiple organs, notably the skin, nails and mucosae. The objective of this study is to elucidate the dermatologic manifestations, associated symptoms, pathophysiology and management recommendations of HH. We searched five primary databases (PubMed, Embase, Cochrane Library, Scopus and Web of Science) up to April 2023. Non-English articles were included to minimize language bias. The studies were evaluated using Oxford Centre for Evidence-based Medicine standards, with adherence to PRISMA guidelines. Inaccessible articles were directly sourced from authors. Out of the initial 1582 publications from 1904 to 2023, 22 studies (19 in English, 2 in French and 1 in German) were selected. Most reports were from the USA, UK and France and were predominantly case reports, covering 148 patients with skin symptoms related to hereditary hemochromatosis. We collected data on the cutaneous findings and, when available, their histopathological features. The current study highlights the scope, variety and traits of dermatologic symptoms in hereditary hemochromatosis, pinpointing research gaps and areas for future exploration. Our review accentuates the diverse dermatological manifestations of hereditary hemochromatosis, notably hyperpigmentation, hypertrichosis and resistant pruritus, often linked to excessive iron deposition and subsequent impairment of skin cell function. We also found controversial evidence indicating that skin cancers seem to be associated with hereditary hemochromatosis. Porphyria cutanea tarda and hereditary hemochromatosis were frequently reported together. Given hereditary hemochromatosis's genetic nature, early identification in one individual can substantially guide familial care and preemptive interventions. Clinicians should prioritize hereditary hemochromatosis as a differential when patients present with specific dermatological symptoms, especially in sun-exposed regions. A rigorous assessment ensures accurate diagnosis, facilitating optimal management for both the patient and their family.
遗传性血色素沉着症(HH)是一种导致铁吸收过多的遗传性疾病,会影响多个器官,尤其是皮肤、指甲和黏膜。本研究的目的是阐明HH的皮肤表现、相关症状、病理生理学及管理建议。我们检索了截至2023年4月的五个主要数据库(PubMed、Embase、Cochrane图书馆、Scopus和Web of Science)。纳入非英文文章以尽量减少语言偏倚。使用牛津循证医学中心标准对研究进行评估,并遵循PRISMA指南。无法获取的文章直接向作者索取。在1904年至2023年最初的1582篇出版物中,选择了22项研究(19篇英文、2篇法文和1篇德文)。大多数报告来自美国、英国和法国,主要是病例报告,涵盖了148例有遗传性血色素沉着症相关皮肤症状的患者。我们收集了皮肤检查结果的数据,如有可用,还收集了其组织病理学特征。本研究强调了遗传性血色素沉着症皮肤症状的范围、多样性和特征,指出了研究空白和未来探索的领域。我们的综述强调了遗传性血色素沉着症多样的皮肤表现,尤其是色素沉着过度、多毛症和顽固性瘙痒,这些通常与铁沉积过多及随后的皮肤细胞功能受损有关。我们还发现有争议的证据表明皮肤癌似乎与遗传性血色素沉着症有关。迟发性皮肤卟啉症和遗传性血色素沉着症经常一起被报道。鉴于遗传性血色素沉着症的遗传性质,对个体的早期识别可极大地指导家庭护理和预防性干预。当患者出现特定的皮肤症状时,尤其是在阳光暴露部位,临床医生应将遗传性血色素沉着症作为鉴别诊断的重点。严格的评估可确保准确诊断,为患者及其家人提供最佳管理。